Bulletin
Investor Alert

Cerecor Inc.

NAS: CERC

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Nov 14, 2019, 4:00 p.m.

/zigman2/quotes/201368871/composite

$

3.02

Change

-0.31 -9.31%

Volume

Volume 71,569

Quotes are delayed by 20 min

/zigman2/quotes/201368871/composite

Previous close

$ 3.33

$ 3.02

Change

-0.31 -9.31%

Day low

Day high

$2.98

$3.40

Open

52 week low

52 week high

$2.71

$7.65

Open

Insider Actions for Cerecor Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/04/2019 Armistice Capital LLC
Director
1,200,000   Acquisition at $3.13 per share. 3,756,000
08/30/2019 Armistice Capital LLC
Director
24,591   Acquisition at $3.23 per share. 79,428
08/29/2019 Armistice Capital LLC
Director
17,173   Acquisition at $3.21 per share. 55,125
08/27/2019 Simon C. Pedder
Executive Chairman of the Bd; Director
6,734   Acquisition at $2.98 per share. 20,067
08/23/2019 Matthew V. Phillips
Chief Commercial Officer
512,500   Award at $1.07 per share. 548,375
08/19/2019 Armistice Capital LLC
Director
0   Acquisition at $0 per share. 0
08/19/2019 Armistice Capital LLC
Director
1,825   Acquisition at $3.63 per share. 6,624
08/19/2019 Armistice Capital LLC
Director
0   Acquisition at $0 per share. 0
08/19/2019 Armistice Capital LLC
Director
473   Acquisition at $3.5 per share. 1,655
08/16/2019 Armistice Capital LLC
Director
0   Acquisition at $0 per share. 0
08/16/2019 Armistice Capital LLC
Director
9,886   Acquisition at $3.43 per share. 33,908
08/14/2019 Armistice Capital LLC
Director
56,842   Acquisition at $3.37 per share. 191,557
08/13/2019 Armistice Capital LLC
Director
29,188   Acquisition at $3.3 per share. 96,320
08/12/2019 Armistice Capital LLC
Director
13,970   Acquisition at $3.2 per share. 44,704

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
11 Purchases
0 Sales
1,773,182
0
Last 6 months
40 Purchases
1 Sales
2,288,254
300,000
Last 12 months
156 Purchases
2 Sales
2,720,225
306,871

Officers and Executives

Dr. Simon C. Pedder
Executive Chairman
Mr. Joseph M. Miller
Secretary, Chief Financial & Accounting Officer
Dr. Perry Calias
Chief Scientific Officer
Mr. Patrick J. Crutcher
Chief Strategy Officer
Mr. Matthew V. Phillips
Chief Commercial Officer
Dr. Bernadine Heather Fraser
VP-Clinical Operations & Project Management
Mr. Peter S. Greenleaf
Director
Dr. Uli Alf Hacksell
Director
Mr. Steven Joseph Boyd
Director
Mr. James A. Harrell
EVP-Marketing & External Communications
Mr. Keith W. Schmidt
Independent Director
Mr. Phil Gutry
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Link to MarketWatch's Slice.